EGFR and lung adenocarcinoma: The possible reasons might include that (a) according to previous studies, GBP1 might have pro‐survival effects on some oncogenic mutations, such as EGFR mutation, leading to EGFR mutation‐driven tumorigenicity of lung adenocarcinoma19; and (b) in addition, GBP1 might exert oncogenic effect and its high expression might activate oncogenic Wnt/β‐catenin signaling pathway, contributing to the initiation of lung adenocarcinoma.10